Sage Therapeutics, Inc.
SAGE
$8.05
$0.1852.35%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 504.42M | 569.15M | 646.79M | 717.01M | 753.18M |
| Total Receivables | 12.93M | 18.07M | 9.94M | 10.51M | 88.61M |
| Inventory | -- | -- | -- | -- | 1.50M |
| Prepaid Expenses | 13.95M | 16.43M | 28.74M | 26.59M | 24.73M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 1.33M | 1.33M | 1.33M | 1.33M |
| Total Current Assets | 531.30M | 604.99M | 686.81M | 755.44M | 869.35M |
|
|
|||||
| Total Current Assets | 531.30M | 604.99M | 686.81M | 755.44M | 869.35M |
| Net Property, Plant & Equipment | 11.64M | 12.27M | 2.49M | 4.44M | 6.38M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.28M | 5.18M | 7.80M | 7.72M | 6.55M |
| Total Assets | 547.22M | 622.43M | 697.11M | 767.60M | 882.28M |
|
|
|||||
| Total Accounts Payable | 12.70M | 7.13M | 8.65M | 6.48M | 10.32M |
| Total Accrued Expenses | 42.29M | 53.05M | 58.22M | 49.45M | 56.68M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.32M | 83.00K | 1.41M | 3.31M | 5.17M |
| Total Finance Division Other Current Liabilities | 15.31M | 152.00K | 762.00K | 2.57M | 10.59M |
| Total Other Current Liabilities | 15.31M | 152.00K | 762.00K | 2.57M | 10.59M |
| Total Current Liabilities | 71.62M | 60.41M | 69.04M | 61.80M | 82.75M |
|
|
|||||
| Total Current Liabilities | 71.62M | 60.41M | 69.04M | 61.80M | 82.75M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 10.52M | 10.19M | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 82.13M | 70.60M | 69.04M | 61.80M | 82.75M |
|
|
|||||
| Common Stock & APIC | 3.44B | 3.43B | 3.41B | 3.39B | 3.37B |
| Retained Earnings | -2.97B | -2.87B | -2.78B | -2.68B | -2.57B |
| Treasury Stock & Other | -156.00K | 501.00K | -1.09M | -1.19M | -1.21M |
| Total Common Equity | 465.09M | 551.84M | 628.06M | 705.80M | 799.53M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 465.09M | 551.84M | 628.06M | 705.80M | 799.53M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 465.09M | 551.84M | 628.06M | 705.80M | 799.53M |
|
|
|||||
